ACLS icon

Axcelis

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 50%
Negative

Positive
Zacks Investment Research
3 days ago
Why Axcelis Technologies (ACLS) Outpaced the Stock Market Today
Axcelis Technologies (ACLS) concluded the recent trading session at $95.72, signifying a +2.81% move from its prior day's close.
Why Axcelis Technologies (ACLS) Outpaced the Stock Market Today
Positive
The Motley Fool
5 days ago
NuScale Power Is Interesting, but Here's What I'd Buy Instead
NuScale could be an attractive energy source as tech giants monitor nuclear energy developments. However, NuScale is years away from commercialization, which makes it a very risky stock.
NuScale Power Is Interesting, but Here's What I'd Buy Instead
Positive
The Motley Fool
6 days ago
Ignore the Noise: 3 AI Stocks Set to Surge 200% by the End of the Decade
Tech giants remain committed to spending heavily on their AI infrastructure buildouts in 2026. AI chipmakers have led the stock market's rally for several years, but the next wave of growth is likely to come from a different batch of stocks.
Ignore the Noise: 3 AI Stocks Set to Surge 200% by the End of the Decade
Neutral
PRNewsWire
7 days ago
Axcelis to Participate in the 28th Annual Needham Growth Conference
BEVERLY, Mass., Jan. 8, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced management is scheduled to participate at the 28th Annual Needham Growth Conference on Tuesday, January 13th, 2026, at The Lotte NY Palace Hotel in New York, NY.
Axcelis to Participate in the 28th Annual Needham Growth Conference
Neutral
PRNewsWire
8 days ago
Veeco Instruments Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Veeco Instruments Inc. - VECO
NEW YORK and NEW ORLEANS, Jan. 7, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.
Veeco Instruments Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Veeco Instruments Inc. - VECO
Neutral
The Motley Fool
13 days ago
Axcelis Director Sells 2,000 Shares as Veeco Merger Advances Through Regulatory Review
2,000 direct shares were sold for $172,100 at $86.05 per share on Dec. 17, 2025. This transaction represented 21.10% of the executive's direct holdings, reducing the position from 9,477 to 7,477 shares.
Axcelis Director Sells 2,000 Shares as Veeco Merger Advances Through Regulatory Review
Neutral
Zacks Investment Research
22 days ago
Axcelis Technologies (ACLS) Stock Drops Despite Market Gains: Important Facts to Note
In the closing of the recent trading day, Axcelis Technologies (ACLS) stood at $82.8, denoting a -1.08% move from the preceding trading day.
Axcelis Technologies (ACLS) Stock Drops Despite Market Gains: Important Facts to Note
Neutral
Zacks Investment Research
1 month ago
Axcelis Technologies (ACLS) Registers a Bigger Fall Than the Market: Important Facts to Note
Axcelis Technologies (ACLS) reached $86.32 at the closing of the latest trading day, reflecting a -1.08% change compared to its last close.
Axcelis Technologies (ACLS) Registers a Bigger Fall Than the Market: Important Facts to Note
Positive
Seeking Alpha
1 month ago
Axcelis Technologies: Ready For A Gradual Rerating (Rating Upgrade)
Axcelis Technologies is upgraded to BUY after Q3FY25 revenue beat and signs of business stabilization. ACLS announced an all-stock merger with Veeco to diversify end markets and reinforce non-China presence, pending regulatory approval. Free cash flow remains robust at ~$120m annually, yielding 4.5% on market cap, supporting attractive valuation.
Axcelis Technologies: Ready For A Gradual Rerating (Rating Upgrade)
Neutral
PRNewsWire
1 month ago
Axcelis to Showcase Advanced Ion Implant Solutions at SEMICON Japan 2025
BEVERLY, Mass. , Dec. 10, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today its participation in SEMICON Japan 2025, taking place December 17–19 at Tokyo Big Sight in Tokyo, Japan.
Axcelis to Showcase Advanced Ion Implant Solutions at SEMICON Japan 2025